← Eichor
Condition: Hypertriglyceridaemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypertriglyceridaemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569Differential Thrombogenesis by EPA and DHA Mediated by HDL
EARLY_Phase 1 · 1 location(s) · The Miriam Hospital · NCT06494488A Study to Assess the Safety, Tolerability and Efficacy of ION775
Phase 2 · 16 location(s) · Ionis Pharmaceuticals, Inc. · NCT07604974Culturally Adapted Dietary Clinical Trial in PR
NA · 1 location(s) · Harvard School of Public Health (HSPH) · NCT05962372The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
Phase N/A · 4 location(s) · University of Michigan · NCT03087253Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreat
Phase 4 · 1 location(s) · Jianyin Zhou · NCT07720232A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Phase 2 · 1 location(s) · Marea Therapeutics · NCT07199309Vitamin C Administration and Triglycerides Level in Critical Care Patients
Phase N/A · 1 location(s) · Meir Medical Center · NCT06206759Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyc
Phase 2 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07308392a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia
Phase 1/Phase 2 · 1 location(s) · Shanghai JMT-Bio Inc. · NCT07140809Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
NA · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07004777Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Phase 1 · 16 location(s) · Verve Therapeutics, Inc. · NCT06451770Pemafibrate for Symptomatic ICAS RCT
NA · 19 location(s) · Tokyo Women's Medical University · NCT07562178RBD5044 in Chinese Participants With Hypertriglyceridemia
Phase 2 · 8 location(s) · Ribotek Biopharmaceuticals (Shandong) Co., Ltd · NCT07587788Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07200674CS-121 APOC3 Base Editing in FCS
EARLY_Phase 1 · 1 location(s) · CorrectSequence Therapeutics Co., Ltd · NCT07176923Abnormal Lipids - Causes and Effects
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT02195050A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis
NA · 1 location(s) · General Hospital of Shenyang Military Region · NCT07388420A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Phase 2 · 41 location(s) · Eli Lilly and Company · NCT07269210Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Phase 3 · 102 location(s) · Arrowhead Pharmaceuticals · NCT06880770Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD
Phase 2 · 4 location(s) · OrsoBio, Inc · NCT06564584A Study of SHR-1918 In Participants With Hypertriglyceridemia
Phase 3 · 1 location(s) · Beijing Suncadia Pharmaceuticals Co., Ltd · NCT07349615Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insu
NA · 1 location(s) · Yale University · NCT05743868Russian Extreme Hypertriglyceridemia Registry
Phase N/A · 6 location(s) · Russian Cardiology Research and Production Center · NCT07508930Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Phase 3 · 294 location(s) · Arrowhead Pharmaceuticals · NCT06822790
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.